Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Tag: GMP non-compliance

Inconsistencies Between Process Validation SOPs and Actual Practices: A Critical GMP Concern

Posted on By

Inconsistencies Between Process Validation SOPs and Actual Practices: A Critical GMP Concern When Process Validation SOPs Diverge from Practice: Closing the GMP Gap Introduction to the Audit Finding 1. Defining the Issue Process validation SOPs are often detailed, but their execution in actual operations may not fully align. This disconnect signals non-compliance and poor oversight….

Read More “Inconsistencies Between Process Validation SOPs and Actual Practices: A Critical GMP Concern” »

GMP Audit Findings, Validation Alignment

Operator Interview Contradictions During Audits: A GMP Compliance Red Flag

Posted on By

Operator Interview Contradictions During Audits: A GMP Compliance Red Flag When Operator Statements Don’t Match SOPs: A Hidden Threat to GMP Compliance Introduction to the Audit Finding 1. SOP vs Practice Discrepancies During regulatory inspections, operators often describe process steps that differ from those documented in SOPs. 2. Red Flag in Audit Interviews Such discrepancies…

Read More “Operator Interview Contradictions During Audits: A GMP Compliance Red Flag” »

GMP Audit Findings, Mismatch Between SOPs and Practice

QC Analysts Using Unapproved Test Methods: A Critical SOP Compliance Risk

Posted on By

QC Analysts Using Unapproved Test Methods: A Critical SOP Compliance Risk Unauthorized Testing Methods in QC Labs: When Practice Strays From SOPs Introduction to the Audit Finding 1. QC Analysts Deviating from SOPs QC analysts use unapproved or alternate test methods not described in the validated SOPs. 2. Informal Practice Becomes Routine Such deviations are…

Read More “QC Analysts Using Unapproved Test Methods: A Critical SOP Compliance Risk” »

GMP Audit Findings, Mismatch Between SOPs and Practice

Staff Unaware of Recent SOP Changes: A Compliance and Training Risk

Posted on By

Staff Unaware of Recent SOP Changes: A Compliance and Training Risk Failure to Communicate SOP Revisions to Staff: A Hidden Compliance Risk Introduction to the Audit Finding 1. SOP Revisions Not Communicated Staff continued following outdated SOPs due to lack of communication of recent changes. 2. Training Logs Incomplete No documented evidence that employees were…

Read More “Staff Unaware of Recent SOP Changes: A Compliance and Training Risk” »

GMP Audit Findings, SOP Training Failure

SOPs Routinely Bypassed in Practice: GMP Non-Adherence Risks and Remedies

Posted on By

SOPs Routinely Bypassed in Practice: GMP Non-Adherence Risks and Remedies Operational SOP Bypass in Pharmaceutical Facilities: A Hidden GMP Threat Introduction to the Audit Finding 1. Informal Practices Operators often develop their own shortcuts, deviating from the approved SOPs. 2. Silent Deviation Culture When SOPs are ignored routinely, deviations become normalized and go undocumented. 3….

Read More “SOPs Routinely Bypassed in Practice: GMP Non-Adherence Risks and Remedies” »

GMP Audit Findings, Non-Adherence

GMP Compliance Risks When SOPs Are Missing for Critical Activities

Posted on By

GMP Compliance Risks When SOPs Are Missing for Critical Activities Addressing the Lack of SOPs for Critical GMP Operations Introduction to the Audit Finding 1. Why SOP Absence is a GMP Concern The absence of Standard Operating Procedures (SOPs) for critical GMP operations is one of the most serious findings in pharmaceutical audits. SOPs provide…

Read More “GMP Compliance Risks When SOPs Are Missing for Critical Activities” »

GMP Audit Findings, SOP Absence

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme